Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective

C Wong, M Stavrou, E Elliott, JM Gregory… - Brain …, 2021 - academic.oup.com
Amyotrophic lateral sclerosis is a progressive and devastating neurodegenerative disease.
Despite decades of clinical trials, effective disease-modifying drugs remain scarce. To …

[HTML][HTML] Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease

CJ Gibbons, RJ Mills, EW Thornton, J Ealing… - Health and quality of life …, 2011 - Springer
Abstract Background The Hospital Anxiety and Depression Scale (HADS) is commonly used
to assess symptoms of anxiety and depression in motor neurone disease (MND). The …

Schwannomatosis: a genetic and epidemiological study

DG Evans, NL Bowers, S Tobi, C Hartley… - Journal of Neurology …, 2018 - jnnp.bmj.com
Objectives Schwannomatosis is a dominantly inherited condition predisposing to
schwannomas of mainly spinal and peripheral nerves with some diagnostic overlap with …

Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP‐43 pathology and not …

Y Davidson, AC Robinson, X Liu, D Wu… - Neuropathology and …, 2016 - Wiley Online Library
Aims A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited
behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND) …

Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis

N Dominik, S Magri, R Currò, E Abati, S Facchini… - Brain, 2023 - academic.oup.com
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) is an autosomal
recessive neurodegenerative disease, usually caused by biallelic AAGGG repeat …

The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease

CA Young, J Ealing, C McDermott… - … Lateral Sclerosis and …, 2019 - Taylor & Francis
Abstract Objectives: Using the Wilson and Cleary model linking clinical variables to quality of
life, we explored the associations between physical and psychological factors, disability …

Missense mutation in the ITPR1 gene presenting with ataxic cerebral palsy: description of an affected family and literature review

J Das, J Lilleker, H Shereef… - … i Neurochirurgia Polska, 2017 - journals.viamedica.pl
Abstract The inositol 1, 4, 5-triphosphate receptor type 1 (ITPR1) gene on chromosome 3
belongs to a family of genes encoding intracellular calcium channel proteins. Such channels …

Personalised virtual gene panels reduce interpretation workload and maintain diagnostic rates of proband-only clinical exome sequencing for rare disorders

LP Molina-Ramírez, C Kyle, JM Ellingford… - Journal of Medical …, 2022 - jmg.bmj.com
Purpose The increased adoption of genomic strategies in the clinic makes it imperative for
diagnostic laboratories to improve the efficiency of variant interpretation. Clinical exome …

[HTML][HTML] Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy

R Behrouzi, X Liu, D Wu, AC Robinson… - Acta neuropathologica …, 2016 - Springer
It has been suggested that patients with motor neurone disease (MND) and those with MND
combined with behavioural variant frontotemporal dementia (bvFTD)(ie FTD+ MND) or with …

[HTML][HTML] Clinical presentation and outcomes of phaeochromocytomas/paragangliomas in neurofibromatosis type 1

A Al-Sharefi, U Javaid, P Perros, J Ealing… - European …, 2019 - ncbi.nlm.nih.gov
Introduction: Patients with neurofibromatosis type 1 (NF1) are at risk of developing
phaeochromocytomas/paragangliomas (PHAEO/PG). Unlike in other familial PHAEO/PG …